These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16436707)

  • 1. Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.
    Wachino J; Kurokawa H; Suzuki S; Yamane K; Shibata N; Kimura K; Ike Y; Arakawa Y
    Antimicrob Agents Chemother; 2006 Feb; 50(2):534-41. PubMed ID: 16436707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-production of SFO-1 and DHA-1 β-lactamases and 16S rRNA methylase ArmA in clinical isolates of Klebsiella pneumoniae.
    Guo Q; Wang P; Ma Y; Yang Y; Ye X; Wang M
    J Antimicrob Chemother; 2012 Oct; 67(10):2361-6. PubMed ID: 22778158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
    Wu JJ; Ko WC; Wu HM; Yan JJ
    J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals.
    Yan JJ; Wu JJ; Ko WC; Tsai SH; Chuang CL; Wu HM; Lu YJ; Li JD
    J Antimicrob Chemother; 2004 Dec; 54(6):1007-12. PubMed ID: 15486082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates.
    Yang J; Ye L; Wang W; Luo Y; Zhang Y; Han L
    Int J Antimicrob Agents; 2011 Oct; 38(4):348-51. PubMed ID: 21724374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
    Wachino J; Doi Y; Yamane K; Shibata N; Yagi T; Kubota T; Ito H; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1960-7. PubMed ID: 15155185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.
    Lee K; Lee M; Shin JH; Lee MH; Kang SH; Park AJ; Yong D; Chong Y
    Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
    Vo AT; van Duijkeren E; Fluit AC; Gaastra W
    Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
    Singtohin S; Chanawong A; Lulitanond A; Sribenjalux P; Auncharoen A; Kaewkes W; Songsri J; Pienthaweechai K
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):271-7. PubMed ID: 20851550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007.
    Mata C; Miró E; Alvarado A; Garcillán-Barcia MP; Toleman M; Walsh TR; de la Cruz F; Navarro F
    J Antimicrob Chemother; 2012 Jan; 67(1):115-22. PubMed ID: 21980067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
    Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
    Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum beta-lactam resistance due to AmpC hyperproduction and CMY-2 coupled with the loss of OMPK35 in Malaysian strains of Escherichia coli and Klebsiella pneumoniae.
    Palasubramaniam S; Subramaniam G; Muniandy S; Parasakthi N
    Microb Drug Resist; 2007; 13(3):186-90. PubMed ID: 17949305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of plasmid replicons encoding the bla(CMY-2) gene in broad-spectrum cephalosporin-resistant Escherichia coli from livestock animals in Japan.
    Hiki M; Usui M; Kojima A; Ozawa M; Ishii Y; Asai T
    Foodborne Pathog Dis; 2013 Mar; 10(3):243-9. PubMed ID: 23489047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.
    Winokur PL; Vonstein DL; Hoffman LJ; Uhlenhopp EK; Doern GV
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2716-22. PubMed ID: 11557460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IncHI2 plasmids harbouring blaVIM-1, blaCTX-M-9, aac(6')-Ib and qnrA genes in the spread of multiresistant Enterobacter cloacae and Klebsiella pneumoniae strains in different units at Hospital Vall d'Hebron, Barcelona, Spain.
    Coelho A; Piedra-Carrasco N; Bartolomé R; Quintero-Zarate JN; Larrosa N; Cornejo-Sánchez T; Prats G; Garcillán-Barcia MP; de la Cruz F; González-Lopéz JJ
    Int J Antimicrob Agents; 2012 Jun; 39(6):514-7. PubMed ID: 22481058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan.
    Muratani T; Kobayashi T; Matsumoto T
    Int J Antimicrob Agents; 2006 Jun; 27(6):491-9. PubMed ID: 16701983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.